by EmVenio | May 12, 2025 | Press Release
DENVER, Colo., May 12, 2025 – Clinical trials organization EmVenio Research was named winner for Best Clinical Trial Company at the 2025 Vaccine Industry Excellence Awards. The award ceremony was held April 22 during the 2025 World Vaccine Congress in Washington, D.C....
by EmVenio | Aug 1, 2024 | Press Release
Pre-study visits now available for clinical research organizations and trial sponsors DURHAM, N.C., Aug. 1, 2024 /PRNewswire/ — EmVenio Research announced today it has opened two dedicated research centers within the Prime Healthcare hospital...
by EmVenio | Jul 23, 2024 | Press Release
Denver, CO., July 23, 2024 – PCM Trials and EmVenio Research, a PCM Trials Company are pleased to announce the addition of Jeff Huntsman to the leadership team as Chief Commercial Officer. Jeff brings over 30 years of experience in commercial planning, global business...
by EmVenio | May 14, 2024 | Press Release
U.S.-based researcher and Health Wizz partner to provide clinical research as a care option DURHAM, N.C., May 14, 2024 – Community research provider EmVenio Research and technology company, Health Wizz are pleased to announce a new partnership to address site...
by EmVenio | May 2, 2024 | Press Release
Joint collaborations bring Boehringer Ingelheim’s Phase III clinical trial to communities through Walgreens pharmacy clinical trial centers and EmVenio’s mobile research units, aimed at improving access to trials DEERFIELD, Ill. and RIDGEFIELD, Conn., May 2, 2024 —...
by EmVenio | Apr 16, 2024 | Press Release
Partnership to provide clinical research to patients across the country DURHAM, N.C., April 16, 2024 – Community research provider EmVenio Research and Prime Healthcare, an award-winning national health system, today announce their partnership to launch the EmVenio...
